Descriptive Study of 123 Symptomatic Patients with IgA Deficiency: A Retrospective Case Series Study
Abstract
Background: IgA deficiency (IgAD) is the most common primary immunodeficiency, which is caused by a defect in IgA antibody production. Most of the patients are asymptomatic. However, patients can present various manifestations. This study was designed to assess the clinical and laboratory manifestations of symptomatic patients with IgA deficiency.
Method: A group of 123 patients with IgA deficiency referred from all over the country to the national immunodeficiency registration center were entered and followed in this study. The data including demographic characteristics, clinical manifestations and laboratory findings recorded at the registry and also the follow-up visits were extracted.
Results: The mean age of studied patients was 17.1 years old. Regarding gender, 45 patients (36.5%) were female. The most common clinical presentations included upper respiratory tract infections in 22 (17.9%), enteropathy in 9 (7.9%), allergic rhinitis in 11 (8.9%), sepsis in 4 (3.3%) patients. Four cases of leukopenia with white blood cell (WBC) <4,000/μl and 21 cases of leukocytosis with WBC> 10,000/μl were observed based on the laboratory results. Moreover, IgG2 and IgG4 in 2 and 11 patients were less than normal rate for their age, respectively.
Conclusion: Although IgA deficient patients are almost always asymptomatic, clinical manifestations such as recurrent sinopulmonary infections, multiple autoimmune diseases, allergic respiratory and skin disorders, gastrointestinal diseases, and rarely severe life-threatening infections could occur.
2. Latiff A H,Kerr M A. The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem. 2007;44(Pt 2):131-9.
3. Kumar V, Jarzabek-Chorzelska M, Sulej J, Karnewska K, Farrell T,Jablonska S. Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis? Clin Diagn Lab Immunol. 2002;9(6):1295-300.
4. Ludvigsson J F, Neovius M,Hammarström L. Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study. J Clin Immunol. 2014;34(4):444-51.
5. Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T, et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol. 2008;147(2):87-92.
6. Bagheri Y, Sanaei R, Yazdani R, Shekarabi M, Falak R, Mohammadi J, et al. The Heterogeneous Pathogenesis of Selective Immunoglobulin A Deficiency. Int Arch Allergy Immunol. 2019;179(3):231-46.
7. Yazdani R, Latif A, Tabassomi F, Abolhassani H, Azizi G, Rezaei N, et al. Clinical phenotype classification for selective immunoglobulin A deficiency. Expert Rev Clin Immunol. 2015;11(11):1245-54.
8. Kardar G A, Shams S H, Pourpak Z,Moin M. Normal value of immunoglobulins IgA, IgG, and IgM in Iranian healthy adults, measured by nephelometry. J Immunoassay Immunochem. 2003;24(4):359-67.
9. Nurkic J, Numanovic F, Arnautalic L, Tihic N, Halilovic D,Jahic M. Diagnostic Significance of Reduced IgA in Children. Med Arch. 2015;69(4):236-9.
10. Moradzadeh R, Nadrian H, Golboni F, Kazemi-Galougahi M H,Moghimi N. Economic inequalities amongst women with osteoporosis-related fractures: an application of concentration index decomposition. Health Promot Perspect. 2016;6(4):190-95.
11. Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol. 2020;40(1):66-81.
12. Modell V, Orange J S, Quinn J,Modell F. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res. 2018;66(3):367-80.
13. Odineal D D,Gershwin M E. The Epidemiology and Clinical Manifestations of Autoimmunity in Selective IgA Deficiency. Clin Rev Allergy Immunol. 2020;58(1):107-33.
14. Bonilla F A, Khan D A, Ballas Z K, Chinen J, Frank M M, Hsu J T, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136(5):1186-205 e1-78.
15. Cataldo F, Marino V, Ventura A, Bottaro G,Corazza G R. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut. 1998;42(3):362-5.
16. El-Metwally A, Toivola P, AlAhmary K, Bahkali S, AlKhathaami A, AlSaqabi M K, et al. The Epidemiology of Celiac Disease in the General Population and High-Risk Groups in Arab Countries: A Systematic Review. Biomed Res Int. 2020;2020:6865917.
17. Özcan C, Metin A, Erkoçoğlu M,Kocabas C N. Bronchial hyperreactivity in children with antibody deficiencies. Allergol Immunopathol (Madr). 2015;43(1):57-61.
18. Živković J, Lipej M, Banić I, Bulat Lokas S, Nogalo B, Lulić Jurjević R, et al. Respiratory and allergic disorders in children with severe and partial immunoglobulin A immunodeficiency. Scand J Immunol. 2019;90(6):e12828.
19. Dominguez O, Giner M, Alsina L, Martin M, Lozano J,Plaza A, editors. Clinical phenotypes associated with selective IgA deficiency: a review of 330 cases and a proposed follow-up protocol. Anales de pediatria (Barcelona, Spain: 2003); 2012.
Files | ||
Issue | Vol 4, No 2 (2021) | |
Section | Original Article | |
DOI | https://doi.org/10.18502/igj.v4i2.9987 | |
Keywords | ||
IgA Deficient Patients Primary Immunodeficiency Disorder Clinical Manifestations Laboratory Results |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |